Neuraxis Inc
NRXS4.350USD
0.0000.00%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
43.01MMarket Cap
LossP/E TTM
More Details of Neuraxis Inc Company
Neuraxis, Inc. is a medical technology company. The Company is focused on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults. It focuses on advancing science and leveraging evidence-based medicine to drive the adoption of its IB-Stim therapy, which is its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim is a food and drug administration (FDA) cleared for functional abdominal pain associated with irritable bowel syndrome (IBS) in adolescents 11-18 years old. The Company’s second product, the Rectal Expulsion Device (RED), is indicated to evaluate the neuromuscular function of a patient’s ability to expel its contents from the rectum and as a qualitative test for rectal hypersensitivity. RED (K242304, 2024) helps identify patients with rectal hypersensitivity who experience a desire or urge defecating at lower volumes of distension.
Neuraxis Inc Info
Ticker SymbolNRXS
Company nameNeuraxis Inc
IPO dateAug 09, 2023
CEOCarrico (Brian Allen)
Number of employees21
Security typeOrdinary Share
Fiscal year-endAug 09
Address11611 N. Meridian St
CityCARMEL
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code46032
Phone18126890791
Websitehttps://neuraxis.com/
Ticker SymbolNRXS
IPO dateAug 09, 2023
CEOCarrico (Brian Allen)
Company Executives of Neuraxis Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Christopher Robin (Chris) Brown
Dr. Christopher Robin (Chris) Brown
Director
Director
792.84K
--
Ms. Kristin A. Ferge
Ms. Kristin A. Ferge
Independent Director
Independent Director
35.94K
+21598.00%
Mr. Brian Carrico
Mr. Brian Carrico
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
20.12K
--
Dr. Adrian Miranda
Dr. Adrian Miranda
Chief Medical Officer, Senior Vice President - Science and Technology
Chief Medical Officer, Senior Vice President - Science and Technology
--
-67441.00%
Dr. Thomas Carrico
Dr. Thomas Carrico
Chief Regulatory Officer, Compliance Officer and Privacy Officer
Chief Regulatory Officer, Compliance Officer and Privacy Officer
--
--
Mr. Timothy R. Henrichs
Mr. Timothy R. Henrichs
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Bradley Mitch Watkins
Mr. Bradley Mitch Watkins
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Beth Keyser
Ms. Beth Keyser
Independent Director
Independent Director
--
--
Mr. Gil Aharon
Mr. Gil Aharon
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Christopher Robin (Chris) Brown
Dr. Christopher Robin (Chris) Brown
Director
Director
792.84K
--
Ms. Kristin A. Ferge
Ms. Kristin A. Ferge
Independent Director
Independent Director
35.94K
+21598.00%
Mr. Brian Carrico
Mr. Brian Carrico
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
20.12K
--
Dr. Adrian Miranda
Dr. Adrian Miranda
Chief Medical Officer, Senior Vice President - Science and Technology
Chief Medical Officer, Senior Vice President - Science and Technology
--
-67441.00%
Dr. Thomas Carrico
Dr. Thomas Carrico
Chief Regulatory Officer, Compliance Officer and Privacy Officer
Chief Regulatory Officer, Compliance Officer and Privacy Officer
--
--
Mr. Timothy R. Henrichs
Mr. Timothy R. Henrichs
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Feb 1
Updated: Sun, Feb 1
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Hannasch (Brian)
10.62%
Bigger Capital Funds, LP
7.52%
Brown (Christopher Robin)
7.44%
AIGH Capital Management, LLC.
2.79%
Money Concepts Capital Corp
2.09%
Other
69.53%
Shareholders
Shareholders
Proportion
Hannasch (Brian)
10.62%
Bigger Capital Funds, LP
7.52%
Brown (Christopher Robin)
7.44%
AIGH Capital Management, LLC.
2.79%
Money Concepts Capital Corp
2.09%
Other
69.53%
Shareholder Types
Shareholders
Proportion
Individual Investor
19.30%
Hedge Fund
9.52%
Investment Advisor
5.50%
Private Equity
2.79%
Investment Advisor/Hedge Fund
1.68%
Venture Capital
0.24%
Other
60.96%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
30
2.04M
19.16%
-230.50K
2025Q3
29
1.61M
16.14%
+370.29K
2025Q2
29
2.67M
34.65%
-516.73K
2025Q1
31
4.67M
62.21%
+933.75K
2024Q4
29
4.04M
56.27%
+476.54K
2024Q3
28
3.89M
54.36%
+476.60K
2024Q2
27
3.62M
51.12%
+229.93K
2024Q1
18
1.89M
32.23%
+1.25M
2023Q4
18
2.14M
36.50%
+1.56M
2023Q3
14
2.07M
34.17%
+2.07M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Hannasch (Brian)
1.13M
10.62%
+430.56K
+61.42%
Jul 01, 2025
Bigger Capital Funds, LP
763.98K
7.17%
+179.98K
+30.82%
Nov 11, 2025
Brown (Christopher Robin)
792.84K
7.44%
--
--
Mar 31, 2025
AIGH Capital Management, LLC.
297.44K
2.79%
--
--
Sep 30, 2025
Money Concepts Capital Corp
33.40K
0.31%
+33.40K
--
Sep 30, 2025
District 2 Capital LP
151.71K
1.42%
+46.15K
+43.72%
Nov 11, 2025
The Vanguard Group, Inc.
71.63K
0.67%
+43.65K
+156.00%
Sep 30, 2025
Parsons Capital Management, Inc.
116.73K
1.1%
--
--
Sep 30, 2025
Worth Venture Partners, LLC
102.56K
0.96%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
50.84K
0.48%
+26.56K
+109.39%
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
